Cardiovascular Diseases Clinical Trial
— Fifty-FiftyOfficial title:
Evaluation of Comprehensive Lifestyle Peer-group-based Intervention on Cardiovascular Risk Factor, a Randomized Controlled Trial: Fifty-Fifty Program
| Verified date | February 2016 |
| Source | Foundation for Science, Health and Education, Spain |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
Cardiovascular disease is the leading cause of death in Spain and worldwide. Interventions
targeting dietary patterns, weight reduction and new physical activity habits often result
in impressive rates of initial behavior changes, but frequently these are not translated
into long term maintenance. We hypothesize that a peer-group intervention, addressing
multiple facets of cardiovascular disease risk factor can be successfully implemented
improving the adherence of participants to healthy habits.
A multicenter, randomized control trial scheme was adopted. A peer-group based intervention
approach in which community members support each other to promote health-enhancing changes
was chosen. Around 600 participants from 7 Spanish municipalities received a 12h initial
training and were randomly allocated to intervention or control groups for a 12-month peer
intervention. Baseline measurements took place before and after the initial training.
Follow-up measurements will be taken at the end of the intervention and 1 and 2 years after
the end of the study. The primary outcome is the improvement in a newly defined score
combining 5 individual variables. Secondary outcomes are 1, 2 and 3 years variations in
anthropometric parameters and/or healthy behaviors.
The project seeks the empowerment of subjects from 25 to 50 years of age to improve their
overall health habits and self-control of risk factor through peer education. The initiative
is being developed in cooperation with the Spanish Agency for Consumer Affairs, Food Safety
and Nutrition (AECOSAN). This study will allow the economic and feasibility evaluation of
the intervention, which will enable policy makers to consider its potential wider
implementation for a real community-based intervention.
| Status | Completed |
| Enrollment | 543 |
| Est. completion date | December 2016 |
| Est. primary completion date | December 2016 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 25 Years to 50 Years |
| Eligibility |
Inclusion Criteria: - Subjects must sign the informed consent and acknowledge the program's objectives. - Subjects must be born between 1963 and 1988 both inclusive. - Subjects must at least present one of the following characteristics: - To be overweight or obese: BMI = 25 kg/m2 - To be physically inactive: carry out less than 150 minutes of exercise a week for periods not less than 10 minutes - To be a smoker - To have high blood pressure Exclusion criteria: - To be unable to meet any of the inclusion criteria - To have been pregnant in January 2013 or to get pregnant during the program - To have a history of any of the chronic diseases given below: - Cardiovascular disease - Cerebrovascular disease - Diabetes mellitus - Other metabolic or endocrine diseases requiring continuous treatment - Pathological oncology - Inflammatory bowel disease - Any other disease of chronic nature requiring continuous treatment with immunosuppressive drugs or corticosteroid therapy - Other reasons and any other disease after the baseline assessment |
| Country | Name | City | State |
|---|---|---|---|
| Spain | Foundation for Science, Health & Education | Madrid |
| Lead Sponsor | Collaborator |
|---|---|
| Foundation for Science, Health and Education, Spain | Nutrition, physical activity and obese prevention Strategy (NAOS), Spanish Agency for Consumer, Nutrition and Food Safety (AECOSAN)., Spanish federation for municipalities and provinces (FEMP). |
Spain,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | The improvement in a newly defined score combining 5 individual variables: the Fuster-BEWAT score | The primary outcome measure is the mean change in the overall Fuster-BEWAT score, which assimilates scores related to Blood pressure, Exercise, Weight, Alimentation and Tobacco. The primary outcome is whether individuals belonging to a lifestyle intervention program (intervention group) demonstrate an improvement of health related behaviors and biological parameters compared to the self-management approach (control group). | 1,2 and 3 year follow-up after the intervention. | |
| Secondary | The mean changes in the individual components of the Fuster-BEWAT score and the mean changes in systolic and diastolic blood pressure levels and Body Mass Index and in the habit parameters evaluated using validated questionnaires. | Anthropometric data of the subjects such weight, height, waist circumference and blood pressure are measured. Information related to eating habits, smoking, physical activity, quality of life, and socio-demographic data is collected using questionnaires: The standardized International Phisical Activity Questionnaire (IPAQ). The shortened Fagerström dependency and the Richmond questionnaires regarding smoking. The "Prevención con dieta mediterránea" (PREDIMED) validated 14-item screening tool for measuring adherence to the Mediterranean diet. A reduced version of SF36 (health survey to measure the overall health) questionnaire for measuring the quality of life. In addition, all participants are asked to provide socio-demographic and report on readiness to change or improving healthy behaviors. |
2 and 3 years |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05650307 -
CV Imaging of Metabolic Interventions
|
||
| Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
| Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
| Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
| Recruiting |
NCT04417387 -
The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
|
||
| Not yet recruiting |
NCT06211361 -
Cardiac Rehabilitation Program in Patients With Cardiovascular Disease
|
N/A | |
| Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
| Recruiting |
NCT04514445 -
The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.
|
||
| Enrolling by invitation |
NCT04253054 -
Chinese Multi-provincial Cohort Study-Beijing Project
|
||
| Completed |
NCT03273972 -
INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers
|
N/A | |
| Completed |
NCT03680638 -
The Effect of Antioxidants on Skin Blood Flow During Local Heating
|
Phase 1 | |
| Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
| Completed |
NCT04083846 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed)
|
Phase 1 | |
| Completed |
NCT04083872 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting)
|
Phase 1 | |
| Completed |
NCT03466333 -
Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia
|
Phase 2 | |
| Completed |
NCT03619148 -
The Incidence of Respiratory Symptoms Associated With the Use of HFNO
|
N/A | |
| Completed |
NCT03693365 -
Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial
|
||
| Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
| Completed |
NCT05132998 -
Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors
|
N/A | |
| Completed |
NCT05067114 -
Solutions for Atrial Fibrillation Edvocacy (SAFE)
|